The Food and Drug Administration (FDA) is reconsidering its limit on compounded weight-loss drugs, or custom-made medications that combine or mix certain ingredients. In response, Hims & Hers Health (HIMS) shares have jumped on this news.

Julie Hyman and Josh Lipton detail these developments on today's Market Domination.

To watch more expert insights and analysis on the latest market action, check out more Market Domination here.

This post was written by Luke Carberry Mogan.